PPARG and colitis: SCFAs can exert anti-inflammatory activity through multiple pathways; Pan et al. [40] reported that SCFAs can activate GPRs receptors in epithelial cells to inhibit the expression of pro-inflammatory factors; on the other hand, butyrate can stimulate the PPAR-γ signaling pathway to improve colitis in mice [21].